Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.
See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.
Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.
Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.
Explore essential insights on batch release processes to enhance compliance and quality. Dive into our article for practical guidance and best practices.

| TITLE/ COMPANY | Issue Date | Status | Details |
|---|---|---|---|
| Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination Strides Pharma Science Ltd. |
20 May 2026 | Normal | Justification: The observation directly concerns line clearance, as residual capsules indicate a lapse in effective clearance. Excerpt: Capsules from the previous batch were observed remaining on the manufacturing line during a Serial Changeover. View Details |
| Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent malfunctions Alkem Laboratories Limited |
01 May 2026 | Normal | Justification: Line clearance should have detected the water droplets before assembly, highlighting gaps in process oversight. Excerpt: Water droplets found inside machine during assembly post line clearance, indicating a potential leak. View Details |
| Procedures describing the handling of written and oral complaints related to drug products are deficiently written or followed. Zydus Lifesciences Limited |
13 Aug 2025 | Normal | Justification: The observation refers to a product recall caused by packaging errors tied to line clearance failures. Excerpt: Revealed the mix-up of about mg with Tablets (b)(4) mg (b)(4) USP, batch during the batch packaging operation. View Details |
| Equipment and utensils are not cleaned, maintained and sanitized at appropriate intervals Blossom Pharmaceuticals |
11 Apr 2025 | Normal | Justification: Observation highlights absent line clearance documentation as critical in contamination prevention. Excerpt: No line clearance had been performed or documented prior to staging these materials. View Details |
| Equipment and utensils are not cleaned, maintained and sanitized at appropriate intervals Blossom Pharmaceuticals |
11 Apr 2025 | Normal | Justification: Observation highlights absent line clearance documentation as critical in contamination prevention. Excerpt: No line clearance had been performed or documented prior to staging these materials. View Details |
View and learn more about FDA Inspections
with our comprehensive list of resources